
iCRT 14
CAS No. 677331-12-3
iCRT 14 ( iCRT14 | iCRT-14 | iCRT 14 | Wnt inhibitor )
产品货号. M18982 CAS No. 677331-12-3
iCRT 14 是一种新型有效的 β-连环蛋白响应转录 (CRT) 抑制剂(在 Wnt 通路活性测定中,IC50= 40.3 nM)。
纯度: >98% (HPLC)






规格 | 价格/人民币 | 库存 | 数量 |
5MG | ¥543 | 有现货 |
![]() ![]() |
10MG | ¥948 | 有现货 |
![]() ![]() |
25MG | ¥1588 | 有现货 |
![]() ![]() |
50MG | ¥2341 | 有现货 |
![]() ![]() |
100MG | ¥3475 | 有现货 |
![]() ![]() |
200MG | 获取报价 | 有现货 |
![]() ![]() |
500MG | 获取报价 | 有现货 |
![]() ![]() |
1G | 获取报价 | 有现货 |
![]() ![]() |
生物学信息
-
产品名称iCRT 14
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述iCRT 14 是一种新型有效的 β-连环蛋白响应转录 (CRT) 抑制剂(在 Wnt 通路活性测定中,IC50= 40.3 nM)。
-
产品描述iCRT14 is a potent inhibitor of β-catenin-responsive transcription (CRT) that inhibits Wnt signaling in a reporter assay in vitro (IC50 = 40.3 nM). It inhibits the interaction between β-catenin and T cell factor 4 (Tcf4) in quantitative reporter assays of β-catenin/Tcf4 binding (Ki = 53.51 μM).
-
体外实验——
-
体内实验——
-
同义词iCRT14 | iCRT-14 | iCRT 14 | Wnt inhibitor
-
通路Others
-
靶点Other Targets
-
受体Wnt
-
研究领域Cancer
-
适应症——
化学信息
-
CAS Number677331-12-3
-
分子量375.44
-
分子式C21H17N3O2S
-
纯度>98% (HPLC)
-
溶解度DMSO : ≥ 29 mg/mL; 77.24 mM
-
SMILESO=C4S\C(=C/c2cc(C)n(c1cccnc1)c2C)C(=O)N4c3ccccc3
-
化学全称5-[[2,5-dimethyl-1-(3-pyridinyl)-1H-pyrrol-3-yl]methylene]-3-phenyl-2,4-thiazolidinedione
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1.Gonsalves FC, et al. Proc Natl Acad Sci USA. 2011 Apr 12;108(15):5954-63.
产品手册




关联产品
-
DAOS
DAOS,Trinder试剂,是一种新型的高水溶性苯胺衍生物。它广泛应用于诊断测试和生化测试。
-
Scutebarbatine A
Scutebarbatine A shows significant antitumor effects on A549 cells in vivo and in vitro via mitochondria-mediated apoptosis by up-regulating expressions of caspase-3 and 9, and down-regulating Bcl-2.
-
Beta-Tocotrienol
Beta-Tocotrienol to serve as a new anticancer agent for treating human lung and brain cancers. It inhibits the growth of both A549 (GI50=1.38±0.334μM) and U87MG (GI50=2.53±0.604μM) cells at rather low concentrations.